Marksans Pharma Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Profit Before Tax	243.26	171.89	132.03	134.51	124.33
Net CashFlow-Operating Activity	31.02	34.05	51.73	50.97	107.07
Net Cash Used In Investing Activity	17.24	-114.22	-194.62	-8.39	8.82
NetCash Used in Fin. Activity	-29.92	-26.21	210.02	75.86	-13.53
Net Inc/Dec In Cash And Equivlnt	18.34	-106.38	67.12	118.44	102.36
Cash And Equivalnt Begin of Year	41.93	148.31	81.19	105.61	3.35
Cash And Equivalnt End Of Year	60.27	41.93	148.31	224.05	105.71

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article